Method for the treatment of cardiac and of vascular hypertrophy and hyperplasia
US5231083A · kind A · utility
Assignee
Inventors
Key dates
| Filing date | Aug 9, 1990 |
| Grant date | Jul 27, 1993 |
| Priority date | — |
| Expiry date | Aug 9, 2010 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention relates to a method for the treatment of cardiac and of vascular hypertrophy and hyperplasia by administration of angiotensin converting enzyme inhibitors. Administration of compounds of the formula I ##STR1## in which n is 1 or 2, R, R.sup.1, R.sup.2 and R.sup.3 are identical or different and each is hydrogen or an organic radical, and R.sup.4 and R.sup.5 form, together with the atoms carrying them, a mono-, bi- or tricyclic heterocyclic ring system, is preferred. The invention additionally relates to angiotensin converting enzyme inhibitors and to agents containing these for administration for the treatment of the abovementioned diseases.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.